Autonomix Medical Stock Forecast

AMIX's stock price has decreased by -92.33% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, Autonomix Medical stock has a consensus rating of "Buy" and an average price target of $40.8. The average 1-year stock price forecast is 2,357.83% higher than the current stock price, while the lowest is $6.00 (+261.45%) and the highest is $75.6 (+4,454.22%).

Price Target: $40.8 (+2,357.83%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$6.00	$40.8	$40.8	$75.6
Change	+261.45%	+2357.8%	+2357.8%	+4454.2%

Analyst Ratings

The average analyst rating for Autonomix Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Aug '25	Nov '25	Dec '25	Feb '26	Jun '26	Oct '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Buy Maintains $42 → $6	Buy	Maintains	$42 → $6	+261.45%	Oct 17, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-8.60

from -48.64

EPS Next Year

-12.06

from -8.60

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	-	-	-	-	-	-
Operating Income	-13.59M	-1.99M	-7.47M	-11.59M	-17.03M	-12.77M
Net Income	-13.33M	-1.99M	-15.43M	-11.41M	-16.72M	-12.60M
EPS	-	-69.52	-311.27	-135.65	-48.64	-8.60
No. Analysts	-	-	-	-	-	2

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2028	2029
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2027	2028	2029
High	-8.60
Avg	-8.60
Low	-8.60

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-